Korea United Pharm Inc
KRX:033270
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Korea United Pharm Inc
Retained Earnings
Korea United Pharm Inc
Retained Earnings Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Korea United Pharm Inc
KRX:033270
|
Retained Earnings
₩422.1B
|
CAGR 3-Years
8%
|
CAGR 5-Years
10%
|
CAGR 10-Years
11%
|
|
|
Yuhan Corp
KRX:000100
|
Retained Earnings
₩2.2T
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
9%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Retained Earnings
-₩354.1B
|
CAGR 3-Years
25%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Retained Earnings
₩836.5B
|
CAGR 3-Years
23%
|
CAGR 5-Years
20%
|
CAGR 10-Years
14%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Retained Earnings
₩96B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
1%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Retained Earnings
₩275.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Korea United Pharm Inc
Glance View
KOREA UNITED PHARM, Inc. engages in the manufacture and distribution of pharmaceuticals and healthcare products. The company is headquartered in Sejong, Sejong and currently employs 885 full-time employees. The company went IPO on 2007-10-23. INC. is a Korea-based company engaged in the manufacture and marketing of pharmaceuticals. The Company’s products include remedies for gastrointestinal system, cardiovascular, hematopoietic system, respiratory system, central nervous system, musculoskeletal system, endocrine and metabolic system, allergy and immune system, as well as anti-infectives, gynecological agents, vitamins, nutrition products, anticancer medicines and others. The company also provides active pharmaceutical ingredients (APIs) and various health food products. The firm distributes its products within domestic market and to overseas markets.
See Also
What is Korea United Pharm Inc's Retained Earnings?
Retained Earnings
422.1B
KRW
Based on the financial report for Sep 30, 2025, Korea United Pharm Inc's Retained Earnings amounts to 422.1B KRW.
What is Korea United Pharm Inc's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
11%
Over the last year, the Retained Earnings growth was 9%. The average annual Retained Earnings growth rates for Korea United Pharm Inc have been 8% over the past three years , 10% over the past five years , and 11% over the past ten years .
